Oncogenic K-Ras suppresses global miRNA function

Published: 12 June 2023| Version 2 | DOI: 10.17632/xhykdcx68t.2
Bing Shui


K-Ras frequently acquires gain-of-function mutations (K-RasG12D being the most common) that trigger significant transcriptomic and proteomic changes to drive tumorigenesis. However, oncogenic K-Ras-induced dysregulation of post-transcriptional regulators such as microRNAs (miRNAs) during oncogenesis is poorly understood. Here we report that K-RasG12D promotes global suppression of miRNA activity, resulting in the up-regulation of hundreds of target genes. We constructed a comprehensive profile of physiological miRNA targets in mouse colonic epithelium and tumors expressing K-RasG12D using Halo-Enhanced Argonaute Pulldown. Combining it with parallel datasets of chromatin accessibility, transcriptome, and proteome, we uncovered that K-RasG12D suppressed expression of Csnk1a1 and Csnk2a1, subsequently decreasing Ago2 phosphorylation at Ser825/829/832/835. Hypo-phosphorylated Ago2 increased binding to mRNAs while reducing its activity to repress miRNA targets. Our findings connect a potent regulatory mechanism of global miRNA activity to K-Ras in a pathophysiological context and provide a mechanistic link between oncogenic K-Ras and the post-transcriptional up-regulation of miRNA targets.



Dana Farber Cancer Institute, Harvard Medical School, Harvard University


Cancer, microRNA